Product Description

Ritulasta (Rituximab) is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids.

Indications

  • Non-Hodgkin's Lymphoma (NHL)
  • Chronic Lymphocytic Leukemia (CLL)
  • Rheumatoid Arthritis
  • Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

Storage

  • Store at 2°C to 8°C
  • Protect from light
  • Do not freeze or shake

Shelf-life

30 months from the date of manufacture

Product Name

Ritulasta


Generic Name

Rituximab


Strengths Avaliable

100 mg in 10 mL, 500 mg in 50 mL